Page last updated: 2024-11-06

1,5-anhydroglucitol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,5-Anhydroglucitol (1,5-AG) is a naturally occurring sugar alcohol found in plants, animals, and humans. It is a cyclic derivative of glucose, formed by the intramolecular dehydration of glucose. 1,5-AG is structurally similar to glucose but lacks the hydroxyl group at the C-5 position, rendering it unable to participate in glycolysis. 1,5-AG is known to be a potent inhibitor of aldose reductase, an enzyme involved in the polyol pathway, which plays a role in diabetic complications. 1,5-AG has been investigated for its potential therapeutic applications in diabetes management and other conditions. 1,5-AG is also a biomarker for hyperglycemia and is often used in the diagnosis and monitoring of diabetes. 1,5-AG is studied to understand its role in glucose metabolism, its potential as a therapeutic agent, and its use as a biomarker for diabetes.'

1,5-anhydroglucitol: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,5-anhydro-D-glucitol : An anhydro sugar of D-glucitol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID64960
CHEMBL ID344637
CHEBI ID16070
SCHEMBL ID114051
MeSH IDM0049207

Synonyms (45)

Synonym
CHEBI:16070 ,
1,5-anhydrosorbitol
(2r,3s,4r,5s)-2-(hydroxymethyl)oxane-3,4,5-triol
154-58-5
1,5-anhydro-d-sorbitol
1,5-anhydro-d-glucitol
1,5-anhydroglucitol
C07326
ASO ,
1-deoxy-d-glucopyranose
CHEMBL344637 ,
bdbm50279834
1-deoxy-1,5-anhydro-d-glucosed-glucitol
1-deoxy-d-glucopyranoside
aceritol
1-deoxy-d-glucose
einecs 205-829-3
d-glucitol, 1,5-anhydro-
54bb3b7xmz ,
unii-54bb3b7xmz
1,5-ag
SCHEMBL114051
W-201390
glucitol, 1,5-anhydro-
MPCAJMNYNOGXPB-SLPGGIOYSA-N
(2r,3s,4r,5s)-2-(hydroxymethyl)tetrahydro-2h-pyran-3,4,5-triol
glucitol, 1,5-anhydro-, d-
1,5-sorbitan
d-glucose, 1-deoxy-
d-glucitol,1,5-anhydro-
AKOS027427035
1,5-anydroglucitol
CS-0059497
HY-113075
A883712
DTXSID60893379
40026-07-1
DTXSID10893389
Q4545703
PS-11742
Y79RBL5ZLQ ,
61792-91-4
1,5-anhydro-glucitol
unii-y79rbl5zlq
PD102027

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Safety endpoints included hypoglycemia and any adverse events."( Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy.
Araki, E; Furukawa, N; Goto, R; Ichimori, S; Iwashita, S; Kawashima, J; Kondo, T; Maeda, T; Matsumura, T; Matsuo, T; Matsuo, Y; Motoshima, H; Nishida, K; Sekigami, T; Shimoda, S, 2013
)
0.39

Bioavailability

ExcerptReferenceRelevance
" Thus the fundamental kinetics of AG were recognized as follows: 1) AG in the body originates mainly from foods and is well absorbed in the intestine, 2) AG is little degraded and metabolized in the body, and 3) an equilibrium exists between oral supplement plus a small but steady amount of de novo synthesis and excretion in urine."( Origin and disposal of 1,5-anhydroglucitol, a major polyol in the human body.
Akanuma, H; Akaoka, I; Minoda, S; Miyashita, H; Moromizato, H; Shinohara, T; Tachibana, Y; Yamanouchi, T, 1992
)
0.59
" This substance is derived mainly from food, is well absorbed in the intestine, and is distributed to all organs and tissues."( Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control.
Akanuma, Y; Yamanouchi, T, 1994
)
0.77

Dosage Studied

ExcerptRelevanceReference
" To evaluate the potential interference of 1, 5-AG measurements by traditional Chinese medicines (Kampo), we examined the 1,5-AG content in 32 types of concentrated dosage forms of Kampo using high performance liquid chromatography (HPLC)."( The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels.
Aiso, Y; Fujimori, S; Inoue, T; Kashiwabara, A; Kawasaki, T; Tanabe, T; Yamanouchi, T; Yoshimura, T, 2000
)
0.31
" This study's primary objective examined the relationship between GSK2141795, an oral, pan-AKT inhibitor, and (18)F-FDG PET markers of glucose metabolism in tumor tissue to determine whether (18)F-FDG PET could be used to guide personalized dosing of GSK2141795."( Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.
Agarwal, R; Babar, S; Blagden, S; Carme, S; Chen, M; Curry, E; Dina, R; El-Bahrawy, MA; Gabra, H; Gungor, H; Krachey, E; Madison, S; Morris, SR; Pickford, E; Rama, N; Saleem, A; Salinas, C; Santiago-Walker, A; Smith, DA; Stronach, EA, 2015
)
0.42
" No dose-response relationship was observed between GSK2141795 pharmacokinetics and (18)F-FDG PET pharmacodynamic measures; however, an exposure-response relationship was seen between maximum drug concentrations and maximal decrease in (18)F-FDG uptake in the best-responding tumor."( Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.
Agarwal, R; Babar, S; Blagden, S; Carme, S; Chen, M; Curry, E; Dina, R; El-Bahrawy, MA; Gabra, H; Gungor, H; Krachey, E; Madison, S; Morris, SR; Pickford, E; Rama, N; Saleem, A; Salinas, C; Santiago-Walker, A; Smith, DA; Stronach, EA, 2015
)
0.42
"We demonstrated a dose-response linear association between 1,5-anhydroglucitol and ACPR."( Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes.
Bao, Y; Hu, G; Lu, J; Lu, W; Ma, X; Mo, Y; Shen, Y; Si, Y; Zhang, L; Zhou, J; Zhu, W, 2020
)
1.12
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
anhydro sugarIntramolecular ethers formally arising by elimination of water from two hydroxy groups of a single molecule of a monosaccharide (aldose or ketose) or monosaccharide derivative.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID588213Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID87444Concentration that induces 50% cell toxicity was determined using monolayers of uninfected HeLa cells1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Uridine 5'-diphosphate glucose analogues. Inhibitors of protein glycosylation that show antiviral activity.
AID588212Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
AID87191Concentration that protects by 50% the cytopathic effect induced by herpes simplex virus - 1.1985Journal of medicinal chemistry, Jan, Volume: 28, Issue:1
Uridine 5'-diphosphate glucose analogues. Inhibitors of protein glycosylation that show antiviral activity.
AID1593958Cytotoxicity against human PHK160b cells assessed as reduction in cell growth at 100 uM incubated up to 96 hrs by MTT assay
AID1593936Induction of keratin-10 expression in human PHK160b cells at 50 uM incubated for 48 hrs by quantitative RT-PCR analysis relative to untreated control
AID588211Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans2010Chemical research in toxicology, Jan, Volume: 23, Issue:1
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (340)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (8.82)18.7374
1990's85 (25.00)18.2507
2000's57 (16.76)29.6817
2010's139 (40.88)24.3611
2020's29 (8.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.89

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.89 (24.57)
Research Supply Index5.97 (2.92)
Research Growth Index5.04 (4.65)
Search Engine Demand Index67.11 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (43.89)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials39 (11.08%)5.53%
Reviews26 (7.39%)6.00%
Case Studies1 (0.28%)4.05%
Observational6 (1.70%)0.25%
Other280 (79.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]